<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04684238</url>
  </required_header>
  <id_info>
    <org_study_id>SED002</org_study_id>
    <nct_id>NCT04684238</nct_id>
  </id_info>
  <brief_title>Effect &amp; Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old</brief_title>
  <acronym>IsoCOMFORT</acronym>
  <official_title>A Randomised Active-controlled Study to Compare Efficacy &amp; Safety of Inhaled Isoflurane Delivered by the AnaConDa-S (Anaesthetic Conserving Device) vs IV Midazolam for Sedation in Mechanically Ventilated Paediatric Patients 3-17 Years Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sedana Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sedana Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to compare safety and efficacy of inhaled isoflurane delivered by the&#xD;
      AnaConDa-S versus intravenous midazolam for sedation in mechanically ventilated children&#xD;
      admitted to an intensive care unit.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III, multi-centre, prospective, randomized, active-controlled, assessor-blind&#xD;
      study. Primary endpoint: percentage of time of adequately maintained sedation, in absence of&#xD;
      rescue sedation, within the COMFORT-B interval (light, moderate, or deep sedation) prescribed&#xD;
      at randomization, monitored every 2 hours for an expected minimum of 12 hours (up to 48&#xD;
      hours).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time adequate sedation depth</measure>
    <time_frame>Minimum of 12 hours up to 48 hours (± 6 hours).</time_frame>
    <description>To compare the percentage of time adequate sedation depth is maintained within the individually prescribed target range in absence of rescue sedation as assessed according to the COMFORT-B scale, in isoflurane vs midazolam treated paediatric patients for an expected minimum of 12 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the use of opiates</measure>
    <time_frame>Minimum of 12 hours up to 48 hours (± 6 hours).</time_frame>
    <description>Compare the use of opiates, and the development of tolerance to the sedative regimen as measured by the change in dose of study drug,opiates and other analgesics, over time in isoflurane- vs midazolam treated patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the need for rescue sedatives</measure>
    <time_frame>Minimum of 12 hours up to 48 hours (± 6 hours).</time_frame>
    <description>Compare the need for rescue sedatives and other sedatives in isoflurane- vs midazolam-treated patients.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Drug: Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Midazolam for sedation in the ICU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug: Isoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volatile for sedation in the ICU</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Solution for Injection/Infusion</description>
    <arm_group_label>Drug: Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <description>Inhalation vapour, liquid. Isoflurane delivered by the AnaConDa-S (Anaesthetic Conserving Device)</description>
    <arm_group_label>Drug: Isoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients at least 3 years to 17 (less than 18) years at the time of randomization,&#xD;
             admitted to an ICU/with planned ICU admission.&#xD;
&#xD;
          -  Expected mechanical (invasive) ventilation and sedation for at least 12 hours.&#xD;
&#xD;
          -  Informed consent obtained from the patient, patient's legal guardian(s)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ongoing seizures requiring acute treatment.&#xD;
&#xD;
          -  Continuous sedation for more than 72 hours at time of randomization.&#xD;
&#xD;
          -  Less than 24 hours post cardiopulmonary resuscitation.&#xD;
&#xD;
          -  Uncompensated circulatory shock.&#xD;
&#xD;
          -  Known or suspected genetic susceptibility to malignant hyperthermia.&#xD;
&#xD;
          -  Patients with acute asthma or obstructive lung disease symptoms requiring treatment at&#xD;
             inclusion.&#xD;
&#xD;
          -  Patient with tidal volume below 30 mL or above 800 mL.&#xD;
&#xD;
          -  Inability to perform reliable COMFORT-B assessment in the opinion of the Investigator&#xD;
&#xD;
          -  Patients with intracranial pressure (ICP) monitoring or with suspected increase in ICP&#xD;
&#xD;
          -  Patients with treatment-induced whole-body hypothermia.&#xD;
&#xD;
          -  Patients with pheochromocytoma.&#xD;
&#xD;
          -  Patients with prolonged QT interval or with significant risk for prolonged QT&#xD;
             interval.&#xD;
&#xD;
          -  Patient not expected to survive next 48 hours or not committed to full medical care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnus Falkenhav, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sedana Medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magnus Falkenhav, MD</last_name>
    <phone>+46 70 856 1687</phone>
    <email>magnus.falkenhav@sedanamedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens-Picardie Site Sud</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de NANTES, Hôpital Mère-Enfant</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Universitaire Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert-Debré AP-HP</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Est Parisien Trousseau La Roche-Guyon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Paris Sud Site Bicetre</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Reims</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil Sant Joan de Deu Hospital</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario, Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio de Sevilla</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politecnic La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitetssjukhus Solna</name>
      <address>
        <city>Solna</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Spain</country>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Eifinger F, Hünseler C, Roth B, Vierzig A, Oberthuer A, Mehler K, Kribs A, Menzel C, Trieschmann U. Observations on the effects of inhaled isoflurane in long-term sedation of critically Ill children using a modified AnaConDa©-system. Klin Padiatr. 2013 Jul;225(4):206-11. doi: 10.1055/s-0033-1345173. Epub 2013 Jun 24.</citation>
    <PMID>23797368</PMID>
  </reference>
  <reference>
    <citation>Ariyama J, Hayashida M, Shibata K, Sugimoto Y, Imanishi H, O-oi Y, Kitamura A. Risk factors for the development of reversible psychomotor dysfunction following prolonged isoflurane inhalation in the general intensive care unit. J Clin Anesth. 2009 Dec;21(8):567-73. doi: 10.1016/j.jclinane.2009.01.011.</citation>
    <PMID>20122588</PMID>
  </reference>
  <reference>
    <citation>Grant MJ, Balas MC, Curley MA; RESTORE Investigative Team. Defining sedation-related adverse events in the pediatric intensive care unit. Heart Lung. 2013 May-Jun;42(3):171-6. doi: 10.1016/j.hrtlng.2013.02.004. Review.</citation>
    <PMID>23643411</PMID>
  </reference>
  <reference>
    <citation>Hoemberg M, Vierzig A, Roth B, Eifinger F. Plasma fluoride concentrations during prolonged administration of isoflurane to a pediatric patient requiring renal replacement therapy. Paediatr Anaesth. 2012 Apr;22(4):412-3. doi: 10.1111/j.1460-9592.2012.03814.x.</citation>
    <PMID>22380747</PMID>
  </reference>
  <reference>
    <citation>Kruessell MA, Udink ten Cate FE, Kraus AJ, Roth B, Trieschmann U. Use of propofol in pediatric intensive care units: a national survey in Germany. Pediatr Crit Care Med. 2012 May;13(3):e150-4. doi: 10.1097/PCC.0b013e3182388a95.</citation>
    <PMID>22079951</PMID>
  </reference>
  <reference>
    <citation>Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community*. Crit Care Med. 2014 Jul;42(7):1592-600. doi: 10.1097/CCM.0000000000000326.</citation>
    <PMID>24717461</PMID>
  </reference>
  <reference>
    <citation>Nolent P, Laudenbach V. [Sedation and analgesia in the paediatric intensive care unit]. Ann Fr Anesth Reanim. 2008 Jul-Aug;27(7-8):623-32. doi: 10.1016/j.annfar.2008.04.014. Epub 2008 Jul 9. French.</citation>
    <PMID>18614330</PMID>
  </reference>
  <reference>
    <citation>Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):523-38. Review.</citation>
    <PMID>16013698</PMID>
  </reference>
  <reference>
    <citation>Meyburg J, Dill ML, von Haken R, Picardi S, Westhoff JH, Silver G, Traube C. Risk Factors for the Development of Postoperative Delirium in Pediatric Intensive Care Patients. Pediatr Crit Care Med. 2018 Oct;19(10):e514-e521. doi: 10.1097/PCC.0000000000001681.</citation>
    <PMID>30059477</PMID>
  </reference>
  <reference>
    <citation>Mody K, Kaur S, Mauer EA, Gerber LM, Greenwald BM, Silver G, Traube C. Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect. Crit Care Med. 2018 Sep;46(9):1486-1491. doi: 10.1097/CCM.0000000000003194.</citation>
    <PMID>29727363</PMID>
  </reference>
  <reference>
    <citation>Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, Hinson G, Mayer A, Morton N, Ralph T, Wolf A; United Kingdom Paediatric Intensive Care Society Sedation; Analgesia and Neuromuscular Blockade Working Group. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med. 2006 Aug;32(8):1125-36. Epub 2006 May 13.</citation>
    <PMID>16699772</PMID>
  </reference>
  <reference>
    <citation>Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med. 2004 Nov;32(11):2241-6.</citation>
    <PMID>15640636</PMID>
  </reference>
  <reference>
    <citation>Sackey PV, Martling CR, Radell PJ. Three cases of PICU sedation with isoflurane delivered by the 'AnaConDa'. Paediatr Anaesth. 2005 Oct;15(10):879-85.</citation>
    <PMID>16176317</PMID>
  </reference>
  <reference>
    <citation>Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000 Jun;28(6):2122-32. Review.</citation>
    <PMID>10890677</PMID>
  </reference>
  <reference>
    <citation>Vet NJ, Ista E, de Wildt SN, van Dijk M, Tibboel D, de Hoog M. Optimal sedation in pediatric intensive care patients: a systematic review. Intensive Care Med. 2013 Sep;39(9):1524-34. doi: 10.1007/s00134-013-2971-3. Epub 2013 Jun 19. Review.</citation>
    <PMID>23778830</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>December 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sedation</keyword>
  <keyword>isoflurane</keyword>
  <keyword>mechanically ventilation</keyword>
  <keyword>pediatric</keyword>
  <keyword>midazolam</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

